Search

Filters

Clear Filters
8:05 AM - 8:10 AM ET

1036 - A Prospective Study of Adaptive MRI-Guided Dose-Escalated Radiation Therapy for Locally Advanced Rectal Cancer
Speaker: Palm, Russell, MD - The Ohio State University James Cancer Hospital, Columbus, OH
8:10 AM - 8:15 AM ET

1037 - Neoadjuvant Chemoradiotherapy with Modern Bowel-Sparing IMRT for Locally Advanced Rectal Cancer: A Multi-Institutional Phase II Trial
Speaker: Sakanaka, Katsuyuki, MD, PhD - Kindai University, Osaka-Sayama, Osaka
8:15 AM - 8:20 AM ET

1038 - Distinct Efficacy between Very Early-Onset Locally Advanced Rectal Cancer (VEO-LARC) and Late-Onset LARC Receiving Total Neoadjuvant Therapy with or without Immunotherapy
Speaker: He, Luoxi - Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai
8:20 AM - 8:25 AM ET

1039 - CXCL12-Driven Anti-Tumor Neutrophil Infiltration Predicts Pathological Complete Response in pMMR Rectal Cancer Treated with Neoadjuvant SCRT and PD-1 Blockade
Speaker: He, Meng, MD, PhD - National Cancer Center/National Clinical Research Center for Cancer Cancer Hospital, CAMS & PUMC, Beijing, Beijing
3:30 PM - 3:40 PM ET

104 - Multimodal Artificial Intelligence Model for Predicting Treatment Efficacy and Optimizing Upfront Cranial Radiotherapy Selection in Third-Generation EGFR-TKI-Treated NSCLC with Brain Metastases
Speaker: Ni, Jianjiao, MD - Fudan University Shanghai Cancer Center, Shanghai, DC
8:00 AM - 8:05 AM ET

104 - Multimodal Artificial Intelligence Model for Predicting Treatment Efficacy and Optimizing Upfront Cranial Radiotherapy Selection in Third-Generation EGFR-TKI-Treated NSCLC with Brain Metastases
Speaker: Ni, Jianjiao, MD - Fudan University Shanghai Cancer Center, Shanghai, DC
8:25 AM - 8:30 AM ET

1040 - Tumor-Informed Circulating Tumor DNA for Prediction of Organ Preservation and Enhanced Surveillance in Locally Advanced Rectal Cancer: A Real-World Cohort
Speaker: Ravella, Revathi, MD - Memorial Sloan Kettering Cancer Center, New York, NY
8:30 AM - 8:35 AM ET

1041 - Durability of Watch-and-Wait after Long- vs. Short-Course Radiation In Total Neoadjuvant Therapy for Rectal Cancer
Speaker: Ravella, Revathi, MD - Memorial Sloan Kettering Cancer Center, New York, NY
3:05 PM - 3:10 PM ET

1042 - Inferring the Initiation Site of Brain Necrosis from Proton Therapy via Inverse Mechanistic Modeling
Speaker: Cogno, Nicolo, PhD - Mass General Brigham Cancer Institute, Boston, MA
3:10 PM - 3:15 PM ET

1043 - The Influence of Cancer Primary Site on Outcomes after Preoperative Radiosurgery for Resected Brain Metastases: A XXX International Multicenter Cohort Study
Speaker: Prabhu, Roshan, MD, MS - Atrium Health Levine Cancer, CHARLOTTE, NC
3:15 PM - 3:20 PM ET

1044 - Proton vs. Photon Craniospinal Irradiation for Leptomeningeal Disease: Comparative Clinical Outcomes and Acute Toxicities
Speaker: Hoang, Audi, BS - Tilman J Fertitta Family College of Medicine, Houston, TX
3:20 PM - 3:25 PM ET

1045 - Pembrolizumab and Stereotactic Radiosurgery (SRS) of Selected Brain Metastases in Breast Cancer Patients
Speaker: Gregucci, Fabiana, MD - Weill Cornell Medical College, New York, NY